The effect of Celox™ Vascular in a Vascular Access Model. Eason et al.

Eason G., Hoggarth A., Alden M., Hardy C., & Ranfield J.

The Symposium on Advanced Wound Care and The Wound Healing Society, Orlando, Florida, April 17-20, 2010, Gaylord Palms Hotel And Convention Center.

Introduction

The Celox™ Vascular product range takes the Celox™ technology from the battlefield into the hospital setting to help medical professionals with their patients bleeding problems. The Celox™ Vascular product comes as an easy to use 2.5cm x 2.5cm pad. When mixed with blood, Celox™ Vascular forms a gel like clot in 30 seconds. This clotting action is independent of the bodies normal clotting processes. Celox™ Vascular s’ clotting ability has been proven to work in the presence of common anti-coagulants such as warfarin and heparin. It also works on hypothermic (cold) blood.

Celox™ Vascular does NOT use non degrading minerals or nano particles, which will remain in the body indefinitely unless completely removed. Celox™ Vascular is made with chitosan, a natural polysaccharide. Chitosan is broken down in the body by lysozyme, a human enzyme, to leave glucosamine, a sugar which is normally found in the body.

The objective of this study is to assess the efficacy of topical hemostat pad, Celox™ Vascular and both negative and positive controls, in a vascular access wound model, to obtain and maintain hemostasis over a period of over 1 hour.

Conclusions

Celox™ Vascular gave very good results with 100% haemostasis following 5 minutes compression. It performed considerably better than both the standard gauze negative control (57% n=7) and the D-Stat Dry positive control (67% n=9).

 

View full poster here.